{"database": "lobbying", "table": "lobbying_activities", "rows": [[2149476, "84d3cf1b-7bd4-474f-841b-acc48288b066", "Q2", "LUPIN PHARMACEUTICALS INC", 401104766, "LUPIN PHARMACEUTICALS INC", 2018, "second_quarter", "CPT", "CREATES Act (S.974/H.R.2212) - addresses REMS and market entry issues.\nPACED Act (S.2514) - restores power to PTO to review patents regardless of sovereign immunity claims\nCARA 2.0 (S.2456/H.R.5311) - addresses opioid abuse crisis", "HOUSE OF REPRESENTATIVES,SENATE", null, 99267, 0, 0, "2018-07-18T10:57:17.273000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["2149476"], "units": {}, "query_ms": 16.412549070082605, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}